HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET
Company Participants
Rob Eno - Chief Executive Officer
Branislav Vajdic - President and Founder
Tim Cruickshank - Chief Financial Officer
Conference Call Participants
Operator
Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation.
Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Throughout today's discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks, particularly under the heading Risk Factors.
A press release detailing these results crossed the wire this afternoon and is available in the Investor Relations section of our company's website, heartbeam.com.
Your host today, Rob Eno, Chief Executive Officer; Branislav Vajdic, President and Founder; Tim Cruickshank, Chief Financial Officer, will present results of operations for the third quarter ended September 30, 2024.
At this time, I will turn the call over to HeartBeam Chief Executive Officer, Mr. Rob Eno.
Rob Eno
Thank you, operator.
The topics we'll cover on today's call are listed on the slide. I'll provide a brief overview of the company's vision and then quickly get into providing an update on the status of our FDA submission, which is top of mind for everyone. We'll then walk you through our management and company updates, financial results and upcoming milestones before turning it over to Q&A.
HeartBeam has developed core technology that enables a new paradigm in cardiac care. HeartBeam's developed the first ever cable-free 12-lead ECG that patients can use wherever they are. We do this by using a vector-based approach, capturing the heart's electrical signals from three dimensions and then synthesizing a 12-lead ECG. This allows users to capture the highest resolution data possible in a patient carried device, far greater than with existing wearables.